Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H3.1, encoded by clustered histone genes such as H3C6, is a basic nuclear protein that forms a core component of the nucleosome, the fundamental unit of chromatin structure in eukaryotes. Two molecules each of H2A, H2B, H3 (including H3.1), and H4 form an octamer around which DNA is wrapped into repeating units called nucleosomes, facilitating DNA packaging in the nucleus. Histone H3.1 is replication-dependent and plays central roles in chromosomal stability, regulation of gene expression, DNA replication, and DNA repair through a variety of post-translational modifications such as methylation, acetylation, and phosphorylation. Mutations in histone H3 genes are implicated in cancers, including diffuse midline glioma. Histone H3.1 is not itself a direct therapeutic target (e.g., a "druggable" receptor or enzyme), but its modifications and mutations are key in epigenetic regulation and disease pathogenesis[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H3.1 (clustered histone 6) (H3.1).